We also heard from some of the cancer services, and particularly from specialist Chris Jackson. What he was talking about was how they had continued to deliver cancer care right through the lockdown—so chemotherapy, radiotherapy, and cancer surgery—and most of the patients that they were looking after had received the care that they needed right through that period. For him, one of the quotes he was saying, during that time, he said, "The lockdown has kept people with cancer and vulnerable immune systems safe. They have been spared the serious or fatal harms of infection. This … to date [has] been a success." I think what he was saying, basically, was that this lockdown has made sure that those with cancer were completely protected from the effects of COVID in the community, along with many, many of us as well. So the success of that lockdown was noted by many. But what he was also talking about was the fact that the lockdown had resulted in delays in some cancer screening and delays in diagnostic tests, and what he was saying was that as a sector, we would need to be planning some catch up in the system for elective procedures and also for non-cancer elective procedures.